JP2007510403A5 - - Google Patents

Download PDF

Info

Publication number
JP2007510403A5
JP2007510403A5 JP2006534768A JP2006534768A JP2007510403A5 JP 2007510403 A5 JP2007510403 A5 JP 2007510403A5 JP 2006534768 A JP2006534768 A JP 2006534768A JP 2006534768 A JP2006534768 A JP 2006534768A JP 2007510403 A5 JP2007510403 A5 JP 2007510403A5
Authority
JP
Japan
Prior art keywords
isoleucine
seq
use according
polypeptide further
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006534768A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007510403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/052572 external-priority patent/WO2005037305A1/en
Publication of JP2007510403A publication Critical patent/JP2007510403A/ja
Publication of JP2007510403A5 publication Critical patent/JP2007510403A5/ja
Pending legal-status Critical Current

Links

JP2006534768A 2003-10-16 2004-10-18 ケモカイン変異体の治療への使用 Pending JP2007510403A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03078308 2003-10-16
PCT/EP2004/052572 WO2005037305A1 (en) 2003-10-16 2004-10-18 Therapeutic uses of chemokine variants

Publications (2)

Publication Number Publication Date
JP2007510403A JP2007510403A (ja) 2007-04-26
JP2007510403A5 true JP2007510403A5 (https=) 2007-12-06

Family

ID=34442986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006534768A Pending JP2007510403A (ja) 2003-10-16 2004-10-18 ケモカイン変異体の治療への使用

Country Status (16)

Country Link
US (1) US7740833B2 (https=)
EP (1) EP1673103A1 (https=)
JP (1) JP2007510403A (https=)
KR (1) KR20070008510A (https=)
CN (1) CN1867352A (https=)
AR (1) AR046594A1 (https=)
AU (1) AU2004281552B2 (https=)
BR (1) BRPI0415290A (https=)
CA (1) CA2536082A1 (https=)
EA (1) EA009414B1 (https=)
IL (1) IL175020A0 (https=)
MX (1) MXPA06003695A (https=)
NO (1) NO20062109L (https=)
UA (1) UA91820C2 (https=)
WO (1) WO2005037305A1 (https=)
ZA (1) ZA200601900B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007021807A1 (en) 2005-08-12 2007-02-22 Schering Corporation Mcp1 fusions
WO2007113285A2 (en) * 2006-03-31 2007-10-11 Biotherapix Molecular Medicines S.L.U. Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors
US20100166733A1 (en) * 2006-06-21 2010-07-01 Zurit Levin Mcp-1 splice variants and methods of using same
ES2434039T3 (es) * 2006-07-24 2013-12-13 Yeda Research And Development Co. Ltd. Composiciones farmacéuticas que comprenden ccl2 para su uso en el tratamiento de la inflamación
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
WO2010086426A1 (en) * 2009-01-30 2010-08-05 Protaffin Biotechnologie Ag Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants
US9249204B2 (en) 2011-06-01 2016-02-02 Jyant Technologies, Inc. Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US20130330337A1 (en) * 2011-06-01 2013-12-12 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
WO2012166588A2 (en) * 2011-06-01 2012-12-06 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
ES2664836T3 (es) * 2011-06-13 2018-04-23 Tla Targeted Immunotherapies Ab Tratamiento de esclerosis múltiple
US9726666B2 (en) 2011-06-13 2017-08-08 Tla Targeted Immunotherapies Ab Diagnosing and treating inflammatory diseases
ES2764840T3 (es) 2015-01-28 2020-06-04 Univ Bordeaux Uso de plerixafor para tratar y/o prevenir exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica
CN107207603A (zh) * 2015-02-03 2017-09-26 吉安特科技股份有限公司 趋化因子‑免疫球蛋白融合多肽,其组合物、制备方法以及用途
WO2018106945A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
EP3554541B1 (en) 2016-12-14 2023-06-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
KR102066149B1 (ko) * 2018-08-17 2020-01-14 고려대학교 산학협력단 Ccl2를 유효성분으로 포함하는 임신촉진용 조성물
EP3883635A1 (en) 2018-11-19 2021-09-29 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
CN115666704B (zh) 2019-12-13 2025-09-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09507211A (ja) * 1993-09-14 1997-07-22 ナショナル ハート アンド ラング インスティチュート エオタキシン:好酸球走化性サイトカイン
US5739103A (en) * 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
US5459128A (en) * 1993-11-12 1995-10-17 Dana-Farber Cancer Institute Human monocyte chemoattractant protein-1 (MCP-1) derivatives
WO1998031794A1 (fr) * 1997-01-17 1998-07-23 Toa Gosei Co., Ltd. Polypeptide liant le facteur vegf
US6100387A (en) * 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
MXPA02001417A (es) * 1999-08-09 2002-08-12 Lexigen Pharm Corp Complejos multiples de citosina-anticuerpo.
US7332474B2 (en) * 2001-10-11 2008-02-19 Amgen Inc. Peptides and related compounds having thrombopoietic activity
AU2002337920A1 (en) * 2001-10-19 2003-04-28 Zymogenetics, Inc. Dimerized growth factor and materials and methods for producing it
AU2003224761A1 (en) * 2002-03-26 2003-10-13 Centocor, Inc. Mcp-1 mutant proteins, antibodies, compositions, methods and uses
AU2003240765A1 (en) * 2002-04-10 2003-10-20 Applied Research Systems Ars Holding N.V. Novel antagonists of mcp proteins
WO2007113285A2 (en) * 2006-03-31 2007-10-11 Biotherapix Molecular Medicines S.L.U. Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors

Similar Documents

Publication Publication Date Title
JP2007510403A5 (https=)
JP2006006329A5 (https=)
JP2006524283A5 (https=)
JP2006503588A5 (https=)
JP2010534684A5 (https=)
JP2013510581A5 (https=)
JP2011508438A5 (https=)
JP2009542225A5 (https=)
JP2007508034A5 (https=)
JP2009504138A5 (https=)
JP2007525988A5 (https=)
JP2018186833A5 (https=)
JP2006511228A5 (https=)
JP2007520565A5 (https=)
JP2006508095A5 (https=)
JP2008542528A5 (https=)
JP2009501689A5 (https=)
JP2009504909A5 (https=)
JP2008519810A5 (https=)
JP2008024962A5 (https=)
JP2008533990A5 (https=)
JP2003284553A5 (https=)
JP2008545719A5 (https=)
JP2007508806A5 (https=)
JP2009509934A5 (https=)